Larimar Therapeutics, Inc. (LRMR) - Latest Market Data

Price & Market Data

Price: $2.37

Daily Change: $0.00 / 0.00%

Range: $2.27 - $2.37

Market Cap: $149,185,008

Volume: 628,640

Performance Metrics

1 Week: 21.99%

1 Month: 3.56%

3 Months: -34.92%

6 Months: -69.06%

1 Year: -63.93%

YTD: -39.79%

Company Details

Employees: 65

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Selected stocks

iCoreConnect Inc. (ICCT)

Elong Power Holding Limited (ELPW)

Oriental Culture Holding LTD (OCG)